Longevity Acquisition Corporation Ordinary Shares
LOAC
LOAC was delisted on the 19th of March, 2021.
10 hedge funds and large institutions have $14.4M invested in Longevity Acquisition Corporation Ordinary Shares in 2020 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 0 closing their positions.
0% more funds holding
Funds holding: 10 → 10 (0)
0% less capital invested
Capital invested by funds: $14.4M → $14.4M (-$46K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 3
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$34.1K |
| 2 |
GCL
Glazer Capital LLC
New York
|
-$10.3K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$910 |
LOAC Hedge Fund Activity: Q3 2020 in Review
10 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Longevity Acquisition Corporation Ordinary Shares (LOAC) for Q3 2020, worth a combined $14.4M — down 0.32% from $14.4M a quarter earlier.
Fund positioning in LOAC was balanced in Q3 2020: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 3 trimmed.
The largest seller was Citadel Advisors, cutting an estimated $34.1K.
- 10 institutional investors held Longevity Acquisition Corporation Ordinary Shares (LOAC) as of Q3 2020, unchanged from Q2 2020.
- Funds reported $14.4M of Longevity Acquisition Corporation Ordinary Shares stock for Q3 2020, down 0.32% quarter-over-quarter.
- 0 funds opened new Longevity Acquisition Corporation Ordinary Shares positions in Q3 2020 and 0 closed out.
- The largest Longevity Acquisition Corporation Ordinary Shares seller in Q3 2020 was Citadel Advisors, an estimated $34.1K sold.
Based on aggregated 13F filings for Q3 2020.